Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302-Reference-Cited by-同舟云学术

Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302

Published:2022-07 Issue: Volume:170 Page:296-304
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Wilson Brooke E.^ORCID,Armstrong Andrew J.^ORCID,de Bono Johann^ORCID,Sternberg Cora N.^ORCID,Ryan Charles J.,Scher Howard I.,Smith Matthew R.,Rathkopf Dana,Logothetis Christopher J.,Chi Kim N.^ORCID,Jones Robert J.^ORCID,Saad Fred,De Porre Peter,Tran NamPhuong,Hu Peter,Gillessen Silke,Carles Joan,Fizazi Karim,Joshua Anthony M.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

2. Abiraterone and increased survival in metastatic prostate cancer;De Bono;N Engl J Med,2011

3. Metformin and reduced risk of cancer in diabetic patients;Evans;BMJ,2005

4. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study;Ruiter;Diabetes Care,2012

5. Antidiabetic medication and prostate cancer risk: a population-based case-control study;Murtola;Am J Epidemiol,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial;European Journal of Cancer;2024-11

2. Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation;Biomedicine & Pharmacotherapy;2024-08

3. Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments;Critical Reviews in Oncology/Hematology;2024-08

4. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04

5. Prostate Cancer and the Mevalonate Pathway;International Journal of Molecular Sciences;2024-02-10